Related Experiment Videos
Severe Raynaud's phenomenon with yohimbine therapy for erectile dysfunction
Sindhu Johnson1, John Iazzetta, Catharine Dewar
1Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada.
The Journal of Rheumatology
|December 17, 2003
Abstract:
Yohimbine is a selective alpha-2 adrenergic antagonist that has been used in the pharmacologic management of erectile dysfunction (ED). We describe a patient with CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia) who paradoxically experienced worsening of Raynaud's phenomenon when using yohimbine for ED.